Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
26.77
+0.44 (1.67%)
At close: Nov 25, 2025, 4:00 PM EST
26.50
-0.27 (-1.01%)
After-hours: Nov 25, 2025, 7:01 PM EST
Progyny Revenue
Progyny had revenue of $313.35M in the quarter ending September 30, 2025, with 9.32% growth. This brings the company's revenue in the last twelve months to $1.27B, up 11.41% year-over-year. In the year 2024, Progyny had annual revenue of $1.17B with 7.22% growth.
Revenue (ttm)
$1.27B
Revenue Growth
+11.41%
P/S Ratio
1.84
Revenue / Employee
$1,865,719
Employees
680
Market Cap
2.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.17B | 78.62M | 7.22% |
| Dec 31, 2023 | 1.09B | 301.69M | 38.34% |
| Dec 31, 2022 | 786.91M | 286.29M | 57.19% |
| Dec 31, 2021 | 500.62M | 155.76M | 45.17% |
| Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PGNY News
- 5 days ago - New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action - GlobeNewsWire
- 6 days ago - Progyny: Growth Has Returned (Rating Upgrade) - Seeking Alpha
- 7 days ago - Does Progyny Stock Lead The Pack? - Forbes
- 12 days ago - Progyny, Inc. to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 19 days ago - Progyny, Inc. (PGNY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Progyny, Inc. Announces Third Quarter 2025 Results - GlobeNewsWire
- 4 weeks ago - Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report - GlobeNewsWire
- 4 weeks ago - Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause - GlobeNewsWire